94 engineering-computation-"https:" "https:" "https:" "https:" "https:" "https:" uni jobs at Nature Careers in United States
Sort by
Refine Your Search
-
We invite applications for a creative and collaborative scientist whose research emphasizes understanding of RNA biology, gene regulation, RNA‐therapeutic and experience in computational and
-
, excelling in engineering and technology. The Zhejiang University International Business School (ZIBS): A premier hub for global business innovation and leadership. iZJU is led by a distinguished team of
-
Job Description Title: Associate or Senior Editor, Nature Computational Science Organization: Nature Portfolio Location: Shanghai, Beijing, New York or New Jersey - Hybrid Working Model Closing date
-
average annual research expenditures exceeding $15 million. The undergraduate program in ESM is the Honors program of the College of Engineering. ESM also hosts 130 PhD students. In addition to the CNEU
-
, information technology, data science, computer science, mathematics, pre-engineering, and engineering. The eight academic departments in the college provide courses of study in each of these areas, in
-
Title: Associate or Senior Editor, Nature Computational Science Organization: Nature Portfolio Location: Shanghai, Beijing, New York or New Jersey - Hybrid Working Model Closing date: January 5th
-
Tenure Track Faculty Position in Biomedical Engineering, Cornell University The Nancy E. and Peter C. Meinig School of Biomedical Engineering at Cornell University invites applications to fill a
-
. Qualifications Candidates must have a Ph.D. in computer science, biology, or psychology (or a related field such as biomedical engineering, statistics, data science, communications, or neuroscience). Candidates
-
. The CSBC is the collaborative interface of the C3D, working with St Jude researchers campus-wide to disseminate and implement the computational technological developments of the C3D. As a Senior
-
-associated Virus (AAV) vector technology and AAV gene therapy approaches. The AAV technology that was developed by the Gene Therapy Center has been directly or indirectly responsible for all FDA approved AAV